These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2296619)

  • 41. Long-term suppression of the cerebral spread of a memory: effects of idazoxan and clonidine.
    Church AC; Flexner LB; Flexner JB; Reynolds EE
    Pharmacol Biochem Behav; 1989 Mar; 32(3):749-56. PubMed ID: 2544908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonism of bencianol (ZY 15051) and idazoxan (RX 781094) to norepinephrine in feline pial arteries in situ.
    Wahl M; Schilling L
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):205-15. PubMed ID: 2872863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolactin (PRL) release-inhibiting properties of the alpha 2 adrenergic receptor antagonist idazoxan: comparison with yohimbine.
    Krulich L; Jurcovicová J; Le T
    Life Sci; 1989; 44(12):809-18. PubMed ID: 2565008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Place conditioning reveals the rewarding aspect of social interaction in juvenile rats.
    Calcagnetti DJ; Schechter MD
    Physiol Behav; 1992 Apr; 51(4):667-72. PubMed ID: 1594664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions.
    Simon P; Dupuis R; Costentin J
    Behav Brain Res; 1994 Mar; 61(1):59-64. PubMed ID: 7913324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment.
    Berridge CW; Dunn AJ
    Psychopharmacology (Berl); 1990; 100(4):504-8. PubMed ID: 2320711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonism of alpha-adrenoceptor agonist-induced antinociception in the rat.
    Hayes AG; Skingle M; Tyers MB
    Neuropharmacology; 1986 Apr; 25(4):397-402. PubMed ID: 2872610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Idazoxan and CH-38083 affect gastric secretion by inhibiting alpha-2 adrenoceptors at vagal and sympathetic pathways.
    Del Tacca M; Blandizzi C; Bernardini MC; Vizi SE
    Acta Physiol Hung; 1990; 75 Suppl():81-2. PubMed ID: 1973574
    [No Abstract]   [Full Text] [Related]  

  • 49. Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094.
    Goldstein JM; Knobloch LC; Malick JB
    Eur J Pharmacol; 1983 Jul; 91(1):101-5. PubMed ID: 6137390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.
    Bill SJ; Boniface A; Haroun F; McAdams RP; Lattimer N; Rhodes KF
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):418-22. PubMed ID: 2881217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Idazoxan and blood gas changes.
    Raptopoulos D; Koutinas A; Moustardas N; Papasteriadis A
    Vet Rec; 1988 Jan; 122(2):47. PubMed ID: 2896410
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of idazoxan on catecholamine systems in rat brain.
    Walter DS; Flockhart IR; Haynes MJ; Howlett DR; Lane AC; Burton R; Johnson J; Dettmar PW
    Biochem Pharmacol; 1984 Aug; 33(16):2553-7. PubMed ID: 6147143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha 2-adrenoceptor antagonists and male sexual behavior: I. Mating behavior.
    Smith ER; Lee RL; Schnur SL; Davidson JM
    Physiol Behav; 1987; 41(1):7-14. PubMed ID: 2891151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
    J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha 2-adrenoceptor blocking properties of idazoxan stereoisomers: stereoselectivity for presynaptic alpha 2-adrenoceptors.
    Martire M; Pistritto G; Preziosi P
    Neurosci Lett; 1988 Apr; 86(3):328-33. PubMed ID: 2837681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-blocking properties of idazoxan (170150 or RX 781094) and its stereoisomers: applications to bronchomotricity.
    Floch A; Advenier C
    J Pharmacol; 1985; 16(3):291-7. PubMed ID: 2866275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Facilitation of the release of noradrenaline and neuropeptide Y by the alpha 2-adrenoceptor blocking agents idazoxan and hydergine in the dog spleen.
    Schoups AA; Saxena VK; Tombeur K; De Potter WP
    Life Sci; 1988; 42(5):517-23. PubMed ID: 2893235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
    Garratt JC; Crespi F; Mason R; Marsden CA
    Eur J Pharmacol; 1991 Jan; 193(1):87-93. PubMed ID: 1710990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low level lead exposure during lactation increases rough and tumble play fighting of juvenile rats.
    Holloway WR; Thor DH
    Neurotoxicol Teratol; 1987; 9(1):51-7. PubMed ID: 3627077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idazoxan blocks the action of noradrenaline but not spinal inhibition from electrical stimulation of the locus coeruleus and nucleus Kolliker-Fuse of the cat.
    Zhao ZQ; Duggan AW
    Neuroscience; 1988 Jun; 25(3):997-1005. PubMed ID: 3405439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.